IRulya Therapeutics QNCX
NASDAQ QNCX
$34.68 -5.59 (-13.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Invested Capital (2022 - 2026)

Updated

IRulya Therapeutics (QNCX) recorded Invested Capital of -$35.32 million in Q2 2026, compared with $28.73 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Invested Capital (2022 - 2026) Analysis & Trends

For FY2025, IRulya Therapeutics reported Invested Capital of -$17.69 million.

  • Across earlier years, Invested Capital came in at $30.15 million in FY2024 (-69.4%), $98.51 million in FY2023 (-2.1%) and $100.59 million in FY2022.
  • The Q2 2026 figure is the lowest quarterly Invested Capital in data going back to Q4 2022.
  • Per Business Quant, the preceding three quarters came in at $15.67 million (Q1 2026), -$17.69 million (Q4 2025) and $18.58 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.32 Mn
Mar 31, 2026 15.67 Mn
Dec 31, 2025 -17.69 Mn
Sep 30, 2025 18.58 Mn
Jun 30, 2025 28.73 Mn
Mar 31, 2025 33.85 Mn
Dec 31, 2024 30.15 Mn
Sep 30, 2024 59.83 Mn
Jun 30, 2024 60.80 Mn
Mar 31, 2024 87.70 Mn
Dec 31, 2023 98.51 Mn
Dec 31, 2022 100.59 Mn
API Access

Quince Therapeutics, Inc. Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=QNCX&period=max&api_key=YOUR_API_KEY